Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 07, 2022 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,104 | -- | 34,845 | |
| Jul 07, 2022 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,195 | -- | -- | |
| Jul 07, 2022 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,123 | -- | 415,887 | |
| Jul 07, 2022 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50,139 | -- | -- | |
| Jul 07, 2022 | SVP Global Operations and R&D | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,480 | -- | 26,354 | |
| Jul 07, 2022 | SVP Global Operations and R&D | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,945 | -- | -- | |
| Jul 07, 2022 | SVP Quality and Regulatory | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,233 | -- | 37,112 | |
| Jul 07, 2022 | SVP Quality and Regulatory | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,452 | -- | -- | |
| Jul 07, 2022 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,188 | -- | 79,686 | |
| Jul 07, 2022 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,357 | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.